PharmiWeb.com - Global Pharma News & Resources
22-Jan-2019

Dementia Associated with Alzheimer's Disease - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dementia Associated With Alzheimer's Disease development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Dementia Associated With Alzheimer's Disease

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Dementia Associated With Alzheimer's Disease

The report assesses the active Dementia Associated With Alzheimer's Disease pipeline products by developmental stage, product type, molecule type, and administration route.

Topics Covered

1. Report Introduction

2. Dementia Associated with Alzheimer's Disease Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical & Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

Companies Featured

  • Otsuka Pharmaceutical Co. Ltd.
  • Eli Lilly Company
  • Novartis
  • Forest Laboratories
  • Adamas Pharmaceuticals Inc.
  • AgeneBio Inc.
  • Amarantus Bioscience Holdings Inc.
  • Boehringer Ingelheim GmbH
  • Chase Pharmaceuticals Corporation
  • Eisai Co. Ltd.
  • H. Lundbeck A/S
  • MediPost Co. Ltd.

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vz9bgn/dementia?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005487/en/

Editor Details

Last Updated: 22-Jan-2019